Prevalence and co-prevalence of comorbidities among Chinese adult patients with type 2 diabetes mellitus: a cross-sectional, multicenter, retrospective, observational study based on 3B study database
- PMID: 38919489
- PMCID: PMC11196810
- DOI: 10.3389/fendo.2024.1362433
Prevalence and co-prevalence of comorbidities among Chinese adult patients with type 2 diabetes mellitus: a cross-sectional, multicenter, retrospective, observational study based on 3B study database
Abstract
Purpose: This study aimed to investigate the prevalence and co-prevalence of comorbidities among Chinese individuals with type 2 diabetes (T2DM).
Methods: Medical records were retrospectively retrieved from the 3B Study database, which provided a comprehensive assessment of comorbid conditions in Chinese adult outpatients with T2DM. Patient characteristics, laboratory measures, and comorbidities were summarized via descriptive analyses, overall and by subgroups of age (<65, 65-74, 75 years) and gender.
Results: Among 25,454 eligible patients, 53% were female, and the median age was 63 years. The median time of diabetes duration was 6.18 years. A total of 20,309 (79.8%) patients had at least one comorbid condition alongside T2DM. The prevalence of patients with one, two, three, and four or more comorbid conditions was 28.0%, 24.6%, 15.6%, and 11.6%, respectively. Comorbidity burden increased with longer T2DM duration. Older age groups also exhibited higher comorbidity burden. Females with T2DM had a higher overall percentage of comorbidities compared to males (42.7% vs. 37.1%). The most common comorbid conditions in T2DM patients were hypertension (HTN) in 59.9%, overweight/obesity in 58.3%, hyperlipidemia in 42.0%, retinopathy in 16.5%, neuropathy in 15.2%, cardiovascular disease (CVD) in 14.9%, and renal disease in 14.4%. The highest co-prevalence was observed for overweight/obesity and HTN (37.6%), followed by HTN and hyperlipidemia (29.8%), overweight/obesity and hyperlipidemia (27.3%), HTN and CVD (12.6%), HTN and retinopathy (12.1%), and HTN and renal disease (11.3%).
Conclusion: The majority of T2DM patients exhibit multiple comorbidities. Considering the presence of multimorbidity is crucial in clinical decision-making.
Systematic review registration: https://clinicaltrials.gov/, identifier NCT01128205.
Keywords: 3B study; co-prevalence; comorbidity; prevalence; type 2 diabetes.
Copyright © 2024 Ji, Chai, Zhang, Li, Zheng and Rajpathak.
Conflict of interest statement
SC, RZ, JL, and YZ are employees of MSD China. SR is an employee of Merck Sharp & Dohme LLC., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus.Curr Med Res Opin. 2016 Jul;32(7):1243-52. doi: 10.1185/03007995.2016.1168291. Epub 2016 Apr 4. Curr Med Res Opin. 2016. PMID: 26986190
-
Sex differences in 10-year ischemic cardiovascular disease risk prediction in Chinese patients with prediabetes and type 2 diabetes.BMC Cardiovasc Disord. 2019 Dec 18;19(1):301. doi: 10.1186/s12872-019-1232-y. BMC Cardiovasc Disord. 2019. PMID: 31881945 Free PMC article.
-
Prevalence and co-prevalence of comorbidities in Belgian patients with type 2 diabetes mellitus: a transversal, descriptive study.Acta Clin Belg. 2018 Feb;73(1):68-74. doi: 10.1080/17843286.2017.1348710. Epub 2017 Jul 5. Acta Clin Belg. 2018. PMID: 28679322
-
Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.Am J Infect Control. 2021 Feb;49(2):238-246. doi: 10.1016/j.ajic.2020.06.213. Epub 2020 Jul 10. Am J Infect Control. 2021. PMID: 32659414 Free PMC article.
-
Type 2 diabetes and hypertension in Vietnam: a systematic review and meta-analysis of studies between 2000 and 2020.BMJ Open. 2022 Aug 8;12(8):e052725. doi: 10.1136/bmjopen-2021-052725. BMJ Open. 2022. PMID: 35940839 Free PMC article.
Cited by
-
Predicting hypertension in type 2 diabetes mellitus: Insights from a nomogram model.World J Diabetes. 2025 Jul 15;16(7):107501. doi: 10.4239/wjd.v16.i7.107501. World J Diabetes. 2025. PMID: 40697588 Free PMC article.
-
Prevalence and Prognostic Impact of Diabetes Mellitus in Hospitalized COVID-19 Patients: A Monocentric Study From India.Cureus. 2025 Jan 4;17(1):e76902. doi: 10.7759/cureus.76902. eCollection 2025 Jan. Cureus. 2025. PMID: 39902024 Free PMC article.
References
-
- International Diabetes Federation . IDF Diabetes Atlas teB. Belgium: International Diabetes Federation; (2021). Available at: http://www.idf.org/.
-
- Available at: https://www.statista.com/topics/6556/diabetes-in-China/.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical